aspirin and extended-release dipyridamole (42571-274)

Drug Facts

Product Profile

Brand Name aspirin and extended-release dipyridamole

Generic Name aspirin and extended-release dipyridamole

Labeler micro labs limited

Dosage Form CAPSULE, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer

Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-274

Product ID 42571-274_336d06cd-6aab-a167-e063-6294a90ad16d

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA209929

Listing Expiration 2026-12-31

Marketing Start 2021-08-16

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571274

Hyphenated Format 42571-274

Supplemental Identifiers

RxCUI

259081

UPC

0342571274603

UNII

R16CO5Y76E 64ALC7F90C

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and extended-release dipyridamole (source: ndc)

Generic Name aspirin and extended-release dipyridamole (source: ndc)

Application Number ANDA209929 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
200 mg/1

source: ndc

Packaging

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60)

source: ndc

Packages (1)

42571-274-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "336d06cd-6aab-a167-e063-6294a90ad16d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0342571274603"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["111a4f6a-c3e4-43e2-8f0e-8c72f71cddb2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60)", "package_ndc": "42571-274-60", "marketing_start_date": "20210816"}], "brand_name": "ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "product_id": "42571-274_336d06cd-6aab-a167-e063-6294a90ad16d", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42571-274", "generic_name": "ASPIRIN and Extended-Release DIPYRIDAMOLE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA209929", "marketing_category": "ANDA", "marketing_start_date": "20210816", "listing_expiration_date": "20261231"}